NEXTURNBIOSCIENCE Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 332.68 million compared to KRW 202.27 million a year ago. Net income was KRW 9,680.99 million compared to net loss of KRW 4,688.26 million a year ago.

Basic earnings per share from continuing operations was KRW 1,041 compared to basic loss per share from continuing operations of KRW 719 a year ago. Diluted earnings per share from continuing operations was KRW 845. Basic earnings per share was KRW 1,087 compared to basic loss per share of KRW 691 a year ago.

Diluted earnings per share was KRW 885.